The Myeloma Crowd
Research Initiative (MCRI)


To get our best possible outcomes, patients need to receive the right treatment at the right time for their unique myeloma. We are funding projects to find the best possible personalized treatments for each patient.

The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. Our goal is to find and fund a cure for multiple myeloma.



Our goal is to provide $500,00 in funding to several research projects to identify optimal therapies for individual patients.

$92,484 of $500,000 Raised

Please help us fully fund these promising research projects by donating today.

Donate to the MCRI


Scientific Advisory Board

C. Ola Landgren, MD, PhD
C. Ola Landgren, MD, PhDChief, Myeloma Service at Memorial Sloan Kettering Cancer Center
Irene Ghobrial, MD, PhD
Irene Ghobrial, MD, PhDDirector, Michele & Stephen Kirsch Laboratory at Dana Farber Cancer Institute
Guido Tricot, MD, PhD
Guido Tricot, MD, PhDDirector, Bone Marrow Transplant and Myeloma Program at Holden Comprehensive Cancer Center, U of Iowa
Noopur Raje, MD, PhD
Noopur Raje, MD, PhDDirector, Multiple Myeloma Program at Raje Laboratory, Massachusetts General Hospital
Rafael Fonseca, MD
Rafael Fonseca, MDDirector, Fonseca Laboratory and Getz Family Professor of Cancer at Mayo Clinic Scottsdale
Robert Orlowski, MD, PhD
Robert Orlowski, MD, PhDDirector of Myeloma at University of Texas MD Anderson Cancer Center

Patient Advisory Board

Jenny Ahlstrom
Jenny AhlstromMyeloma Survivor; Founder of CrowdCare Foundation, Myeloma Crowd, and Myeloma Crowd Radio
Jim Omel, MD
Jim Omel, MDMyeloma Survivor; Support Group Leader; Leading Patient Advocate
Gary Peterson
Gary PetersonMyeloma Survivor; Patient Advocate and Myeloma Survival Statics:
Jack Aiello
Jack AielloMyeloma Survivor; Experienced Patient Advocate
Cynthia Chmielewski
Cynthia ChmielewskiMyeloma Survivor; Experienced Patient Advocate: @MyelomaTeacher
Eric Hansen
Eric HansenMyeloma Survivor; Experienced Patient Advocate

Communications Advisory Board

Mike Thompson, MD, PhD
Mike Thompson, MD, PhDMedical Director, Early Phase Cancer Research Program at Aurora Health Care

Get Started Today.

Find a Clinical Trial that's Right for You


Thanks to our site sponsors: